James Patrick Nolan, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 150 Carnegie Harbor Drive, Portsmouth, RI 02871 Phone: 401-293-0296 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
Today keynote speaker Congresswoman Nita Lowey (NY-18) joined with experts from New York Presbyterian Hospital; the Skin Cancer Foundation; 2006 Miss Maryland, a skin cancer survivor; Fallene LTD, and Ciba Corporation to call on the Food and Drug Administration (FDA) to address the dramatic rise in skin cancer rates in the United States.
The Institute of Medicine (IOM) on Friday released a summary of a joint workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research, titled, "Facing the Reality of Drug-Resistant Tuberculosis: Challenges and Potential Solutions in India."
Researchers at the Children's Hospital of Philadelphia's Center for Injury Research and Prevention studied nearly 1,000 1- to 8-year-old children involved in crashes and found no evidence of increased injury risk for children across a broad weight range. All of the children included in the study were properly restrained in the correct child safety seat or booster seat for their height and weight.
› Verified 7 days ago